Over this 21-day treatment time course, the visible tumor foci or LW/BW ratio progressively trended lower in the LNP-CTNNB1 group although differences were insignificant (except day 5) when compared to time-matched LNP-CTRL group (Figure S6a; Figure 2b). The gene discussed is CTNNB1; the disease is neoplasm.